Beyond Air, Inc. Common Stock
XAIRStock
$5.55−91.12%52W
Market Cap$4.43M
P/E—
Div yield—
Beta0.14
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-75.62%
Price vs S&P 500 (4W)-19.41%
VGM Score59.53
Market Capitalization$4.43M
Earnings Surprise History
Q4 26-12.60est. -11.56
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.00
4.00
4.00
4.00
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
XAIRBeyond Air, Inc. Common Stock | A | A | F | $5.55 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a proprietary nitric oxide (NO) generator and delivery system, extracting NO from ambient air for inhaled therapeutic treatment. The company is advancing its technology for pulmonary hypertension and lower respiratory tract infections.